206 related articles for article (PubMed ID: 10093482)
1. [Interferons: Clinical applications in hematology].
Ben Rhomdhane N; Ben Ahmed M; Zitouni M; Mtimet B
Tunis Med; 1998 Dec; 76(12):427-36. PubMed ID: 10093482
[No Abstract] [Full Text] [Related]
2. Recent publications in hematological oncology.
Hematol Oncol; 2007 Sep; 25(3):148-55. PubMed ID: 17957827
[No Abstract] [Full Text] [Related]
3. [Hematology 2010].
Dreyling M; Subklewe M; Braess J; Spiekermann K
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
[No Abstract] [Full Text] [Related]
4. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
5. [Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].
Bernasconi C
Haematologica; 1990; 75 Suppl 4():82-4. PubMed ID: 2074058
[No Abstract] [Full Text] [Related]
6. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
7. Recent publications in hematological oncology.
Hematol Oncol; 2002 Mar; 20(1):43-50. PubMed ID: 11921016
[No Abstract] [Full Text] [Related]
8. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
9. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
10. Interferon: anticancer agent having multifarious activity.
Yabrov AA
Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
[No Abstract] [Full Text] [Related]
11. Hematology-oncology. Hematology-Oncology Workgroup, Legislative Task Force on Cancer in Texas.
Gardner FH; Alperin JB; Belli JA; Farley PC; Frenkel EP; Redman JR; Roodman GD; Sears DA; Trowbridge AA
Tex Med; 1987 Sep; 83(9 Pt 2):59-71. PubMed ID: 3672407
[No Abstract] [Full Text] [Related]
12. [Hematology 2009].
Dreyling M; Spiekermann K; Hiddemann W
Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1367-9. PubMed ID: 19517333
[No Abstract] [Full Text] [Related]
13. General principles of treatment.
Schouten HC
Ann Oncol; 2007 Jan; 18 Suppl 1():i29-i32. PubMed ID: 17311818
[No Abstract] [Full Text] [Related]
14. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
15. Current status of allogeneic stem cell transplantation for treatment of hematologic malignancies.
Hart DP; Peggs KS
Clin Pharmacol Ther; 2007 Sep; 82(3):325-9. PubMed ID: 17637786
[TBL] [Abstract][Full Text] [Related]
16. [Interferon in the therapy of hemoblastoses (a review)].
Iavorkovskiĭ LI; Iavorkovskiĭ LL
Ter Arkh; 1989; 61(10):33-9. PubMed ID: 2481891
[No Abstract] [Full Text] [Related]
17. What's new in haematology?
Hounsell J; Isbister JP
Med J Aust; 1994 Jan; 160(1):38-40. PubMed ID: 8271984
[No Abstract] [Full Text] [Related]
18. Recent publications in hematological oncology.
Hematol Oncol; 2006 Jun; 24(2):89-96. PubMed ID: 16848029
[No Abstract] [Full Text] [Related]
19. Response evaluation and long-term follow-up.
Schouten HC
Ann Oncol; 2007 Jan; 18 Suppl 1():i33-i36. PubMed ID: 17311820
[No Abstract] [Full Text] [Related]
20. [Cellular immunotherapy for hematopoietic malignancies].
Yasukawa M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():390-4. PubMed ID: 17474435
[No Abstract] [Full Text] [Related]
[Next] [New Search]
